NCAGE THERAPEUTICS S.A.
Registration details
Company overview
NCAGE THERAPEUTICS S.A. is a Join Stock Company registered in Poland under 38487614000000, and its current status with National Court Register (KRS) is active. The company was incorporated on 25 July 2024 and lists its registered address as KRAKÓW, Poland. 2 shareholders are on record for NCAGE THERAPEUTICS S.A., including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO).
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
3
Registry notes and limitations
Three officers are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS). John Bason serves as President Of The Management Board; Christopher Kaplan serves as Vice President Of The Management Board; Jonathan Heddle serves as Member Of The Management Board.
Management authority at NCAGE THERAPEUTICS S.A. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
NCAGE THERAPEUTICS S.A.
Poland
How these relationships were recorded
NCAGE THERAPEUTICS S.A. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans Poland, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Frequently asked questions
Who owns NCAGE THERAPEUTICS S.A.?
Two shareholders are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS). The largest of these is Jonathan Heddle, holding 55.8% — a majority holding — followed by Christopher Lewis Kaplan at 44.2%. Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
Who is NCAGE THERAPEUTICS S.A.'s UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for NCAGE THERAPEUTICS S.A. is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does NCAGE THERAPEUTICS S.A. have on record?
2 shareholders are shown on record for NCAGE THERAPEUTICS S.A..
What is NCAGE THERAPEUTICS S.A.'s company registration number?
NCAGE THERAPEUTICS S.A.'s registration number is 38487614000000, filed with National Court Register (KRS) in Poland. Its current status on the register is active.
Is NCAGE THERAPEUTICS S.A. still an active company?
NCAGE THERAPEUTICS S.A.'s status on National Court Register (KRS) is listed as active.
When was NCAGE THERAPEUTICS S.A. incorporated?
NCAGE THERAPEUTICS S.A. was incorporated on 25 July 2024, according to National Court Register (KRS).
What is NCAGE THERAPEUTICS S.A.'s registered address?
The registered address on file for NCAGE THERAPEUTICS S.A. is KRAKÓW, Poland.
What legal structure is NCAGE THERAPEUTICS S.A. registered as?
NCAGE THERAPEUTICS S.A. is registered as a Join Stock Company in Poland.
Who are the officers/directors of NCAGE THERAPEUTICS S.A.?
Three officers are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS). John Bason serves as President Of The Management Board; Christopher Kaplan serves as Vice President Of The Management Board; Jonathan Heddle serves as Member Of The Management Board. Management authority at NCAGE THERAPEUTICS S.A. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does NCAGE THERAPEUTICS S.A. have a parent company or subsidiaries?
NCAGE THERAPEUTICS S.A. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans Poland, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.